vTv Therapeutics (VTVT) Current Deferred Revenue (2015 - 2024)
vTv Therapeutics' Current Deferred Revenue was $17,000 in Q3 2024, unchanged from $17,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
vTv Therapeutics (VTVT) Current Deferred Revenue (2015 - 2024) Analysis & Trends
From Q2 2015 onward, vTv Therapeutics has reported Current Deferred Revenue for 36 quarters.
- Current Deferred Revenue shows a five-year compound annual growth rate of -60.4% (FY2018 to FY2023).
- In earlier years, Current Deferred Revenue was $17,000 in FY2022 (-51.4%), $35,000 in FY2021 (+12.9%), $31,000 in FY2020 (unchanged) and $31,000 in FY2019 (-98.2%).
- Quarterly Current Deferred Revenue has moved between $17,000 (Q4 2022) and $35,000 (Q1 2022) over five years.
- The best year-over-year quarter for Current Deferred Revenue over five years was Q2 2020 (growth of 14.8%); the worst was Q4 2019 (a decline of 98.2%).
- Per Business Quant data, VTVT's Current Deferred Revenue in the three quarters before Q3 2024 was $17,000 (Q2 2024), $17,000 (Q1 2024) and $17,000 (Q4 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | vTv Therapeutics | 382.70 Mn | 382.70 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 17,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | 17,000.00 |
| Jun 30, 2023 | 17,000.00 |
| Mar 31, 2023 | 17,000.00 |
| Dec 31, 2022 | 17,000.00 |
| Sep 30, 2022 | 26,000.00 |
| Jun 30, 2022 | 26,000.00 |
| Mar 31, 2022 | 35,000.00 |
| Dec 31, 2021 | 35,000.00 |
| Sep 30, 2021 | 35,000.00 |
| Jun 30, 2021 | 35,000.00 |
| Mar 31, 2021 | 35,000.00 |
| Dec 31, 2020 | 31,000.00 |
| Sep 30, 2020 | 31,000.00 |
| Jun 30, 2020 | 31,000.00 |
| Mar 31, 2020 | 31,000.00 |
| Dec 31, 2019 | 31,000.00 |
API Access
vTv Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VTVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "VTVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VTVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();